Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

Angélique Bruyer, MSc, Nicolas Robert, Stéphanie Boireau, Christophe Hirtz, Laurent Tiers, Laure Vincent, Guillaume Cartron, Dirk Hose, MD, Anja Seckinger, Bernard Klein, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 3045.

https://doi.org/10.1182/blood.V130.Suppl_1.3045.3045

Published: 2017

Journal Articles

Inhibition of SUV39H Methyltransferase As a Potent Therapeutic Target in Multiple Myeloma

Julie Devin, Elena Viziteu, Laurie Herviou, Anja Seckinger, MD, Grandmougin Camille, Hartmut Goldschmidt, MD, Laure Vincent, MD, Philippe Pasero, PhD, Dirk Hose, MD, Bernard Klein, PhD, Jerome Moreaux, PhD

Blood (2015) 126 (23): 1771.

https://doi.org/10.1182/blood.V126.23.1771.1771

Published: 2015

Journal Articles

Controlled Epstein-Barr Virus Reactivation After Allogenic Transplantation Improves Survival and Is Associated To An Expansion Of Natural Killer Cells (NK)

Sophie Auger, MD, Mattea Orsini, Patrice Ceballos, MD, Nathalie Fegueux, MD, Bernard Klein, PhD, Martin Villalba, Jean-Francois Rossi, MD, PhD

Blood (2013) 122 (21): 4594.

https://doi.org/10.1182/blood.V122.21.4594.4594

Published: 2013

Journal Articles

Bone Turnover In Multiple Myeloma: Impact Of Bortezomib-Based Induction Therapy, High-Dose Melphalan, and Lenalidomide Consolidation On Osteoblast and Osteoclast Function Within The GMMG-MM5 Trial

Anja Seckinger, MD, Tobias Meißner, PhD, Uta Bertsch, MD, Hans Salwender, MD, Jan Dürig, MD, Mathias Hänel, MD, Igor W. Blau, MD, Christof Scheid, MD, Katja Weisel, MD, Bernard Klein, PhD, Hartmut Goldschmidt, MD, Dirk Hose, Dr. med. dipl.-phys.

Blood (2013) 122 (21): 1863.

https://doi.org/10.1182/blood.V122.21.1863.1863

Published: 2013

Journal Articles

Role Of RECQ1 Helicase In Multiple Myeloma Biology and Drug Resistance

Elena Viziteu, Bernard Klein, PhD, Angelique Bruyer, Dirk Hose, Dr. med. dipl.-phys., Hartmut Goldschmidt, MD, Camille Grandmougin, Jihane Basbous, Angelos Constantinou, Jerome Moreaux, PhD

Blood (2013) 122 (21): 1889.

https://doi.org/10.1182/blood.V122.21.1889.1889

Published: 2013

Journal Articles

Expression Quantitative Trait Loci Reveal Regulatory Regions Important In The Pathogenesis of Multiple Myeloma

Blood (2013) 122 (21): 1847.

https://doi.org/10.1182/blood.V122.21.1847.1847

Published: 2013

Journal Articles

Malignant Plasma Cells Responsible for Multiple Myeloma Relapse Are Detectable and Survive Nine Days After High Dose Melphalan: Highlight of An Optimal Therapeutic Window ?

Anouk Caraux, PhD, Laure Vincent, Jerome Moreaux, PhD, Guilhem Requirand, Caroline Bret, PharmD, PhD, Jean-Luc Veyrune, PhD, Christophe Duperray, Salahedine Bouhya, MD, Jean-Francois Rossi, MD, PhD, Bernard Klein, PhD

Blood (2011) 118 (21): 131.

https://doi.org/10.1182/blood.V118.21.131.131

Published: 2011

Journal Articles

Umbilical Cord Blood Transplantion In Relapsed Multiple Myeloma

Nathalie Fegueux, MD, Meniane Jean-Come, MD, Laure Vincent, Patrice Ceballos, MD, Tarik Kanouni, MD, Jean-Francois Eliaou, MD, PhD, Bernard Klein, PhD, Jean-Francois Rossi, MD, PhD

Blood (2010) 116 (21): 2374.

https://doi.org/10.1182/blood.V116.21.2374.2374

Published: 2010

Journal Articles

Immunophenotypic Analysis of Myeloma Precursors: Antigens for Therapeutic Targeting

Martin Perez-Andres, PhD, Bruno Paiva, Leandro Thiago, PhD, Nico A Bos, PhD, MD, Dirk Hose, PhD, MD, Bernard Klein, PhD, MD, Surinder S Sahota, PhD, Pieter Sonneveld, MD, PhD, Karin Vanderkerken, PhD, Niklas Zojer, PhD, MD, Hans Erik Johnsen, MD, Jesus F San Miguel, Alberto Orfao

Blood (2010) 116 (21): SCI-5.

https://doi.org/10.1182/blood.V116.21.SCI-5.SCI-5

Published: 2010

Journal Articles

Myeloma Cell Self-Renewal Depends on JAG2 Expression and Is Mediated by IGF1 or SCF Loop

David Chiron, PhD, in, training, Sophie Maiga, Géraldine Descamps, Severine Marionneau, Thilbaud Ouiller, Jerome Moreaux, Bernard Klein, PhD, MD, Philippe Moreau, Jean-Luc Harousseau, Regis Bataille, MD, PhD, Martine Amiot, Catherine Pellat-Deceunynck, PhD

Blood (2010) 116 (21): 127.

https://doi.org/10.1182/blood.V116.21.127.127

Published: 2010

Journal Articles

Comparison of Immune Reconstitution after Umbilical Cord Blood (UCB) and Allogenic Peripheral Blood Stem Cell (APBSC) Transplantation in Patients with Advanced Multiple Myeloma (MM) and Acute Myeloid Leukemia (AML).

Jean-Come Meniane, MD, Patrice Ceballos, MD, Maud Condomines, PhD, Jean-françois Eliaou, MD PhD, Nathalie Fegueux, MD, Bernard Klein, PhD, Jean-françois Rossi, MD PhD

Blood (2007) 110 (11): 5008.

https://doi.org/10.1182/blood.V110.11.5008.5008

Published: 2007

Journal Articles

Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma.

Jerome Moreaux, PhD, Anne-Catherine Sprynski, Karene Mahtouk, PhD, Philippe Moine, Nicolas Robert, Jean-François Rossi, MD, PhD, Bernard Klein, PhD

Blood (2007) 110 (11): 3522.

https://doi.org/10.1182/blood.V110.11.3522.3522

Published: 2007

Journal Articles

Interest of FDG-PET Scanning for the Monitoring of Immunotherapies for Follicular Lymphoma.

Marion Baudard, MD, PhD, Frederic Comte, MD, Anne Marie Conge, PhD, Denis Mariano-Goulart, MD, Bernard Klein, PhD, Jean-Francois Rossi, MD, PhD

Blood (2006) 108 (11): 5184.

https://doi.org/10.1182/blood.V108.11.5184.5184

Published: 2006

Journal Articles

Biological and Clinical Responses after Intradermal and Intravenous Administrations of Mature Dendritic Cells Loaded with Tumor Lysate in Follicular Lymphoma Patients.

Marion Baudard, MD, PhD, Anne Marie Conge, PhD, Jean-Luc Veyrune, PhD, Maud Condomines, pharmD, Bernard Klein, PhD, Jean-Francois Rossi, MD, PhD

Blood (2006) 108 (11): 5185.

https://doi.org/10.1182/blood.V108.11.5185.5185

Published: 2006

Journal Articles

Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Vaccination Strategies Determined by Microarray Analysis.

Maud Condomines, PharmD, Dirk Hose, MD, PhD, Thierry Reme, PhD, Michael Hundemer, John De Vos, MD, PhD, Marion Baudard, MD, PhD, Thomas Moehler, Veronique Pantesco, Jean-Francois Schved, MD, PhD, Jean-Francois Rossi, MD, PhD, Hartmut Goldschmidt, MD, PhD, Bernard Klein, PhD

Blood (2006) 108 (11): 3401.

https://doi.org/10.1182/blood.V108.11.3401.3401

Published: 2006

Journal Articles

Characterization of Mesenchymal Stem Cells Abnormalities in Multiple Myeloma.

Philippe Bourin, MD, PhD, Jill Corre, PharmD, Karène Mahtouk, PhD, Mélanie Gadelorge, Ing, Patrick Laharrague, MD, PhD, Bernard Klein, PhD, Thierry Rème, MD, PhD, Michel Attal, MD, PhD

Blood (2006) 108 (11): 511.

https://doi.org/10.1182/blood.V108.11.511.511

Published: 2006

Journal Articles

A Phase I/II Study of TACI-Ig To Neutralize APRIL and BLyS in Patients with Refractory or Relapsed Multiple Myeloma or Active Previously-Treated Waldenström’s Macroglobulinemia.

Jean-Francois Rossi, MD, Isabelle Borghini-Fuhrer, PhD, Jerôme Moreaux, Guilhem Requirand, Said Bouseida, Marie Picard, Arnaud Ythier, MD, Eric Sievers, MD, Bernard Klein, PhD

Blood (2005) 106 (11): 2566.

https://doi.org/10.1182/blood.V106.11.2566.2566

Published: 2005

Journal Articles

Efficient Vaccination of Follicular Lymphoma (FL) Patients with Multiple Intradermal (ID) and Intravenous (IV) Administrations of Mature Dendritic Cells (DC) Loaded with Tumor Cell Lysate Ex Vivo.

Jean-Francois Rossi, MD, PhD, Marion Baudard, MD, Anne-Marie Conge, PhD, Frédéric Comte, MD, Valérie Costes, MD, Jean-Luc Veyrunes, PhD, Philippe Quittet, MD, Valérie Rouillé, Catherine Barjot, PhD, Bernard Klein, PhD

Blood (2005) 106 (11): 1494.

https://doi.org/10.1182/blood.V106.11.1494.1494

Published: 2005

Journal Articles

The Human Plasma Cell Gene Expression Program.

John De Vos, MD, PhD, Dirk Hose, MD, PhD, Thierry Reme, MD, PhD, Hartmut Goldschmidt, MD, PhD, Jean-Francois Rossi, MD, PhD, Friedrich Cremer, MD, PhD, Bernard Klein, PhD

Blood (2004) 104 (11): 3242.

https://doi.org/10.1182/blood.V104.11.3242.3242

Published: 2004

NARROW

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

Inhibition of SUV39H Methyltransferase As a Potent Therapeutic Target in Multiple Myeloma

Controlled Epstein-Barr Virus Reactivation After Allogenic Transplantation Improves Survival and Is Associated To An Expansion Of Natural Killer Cells (NK)

Bone Turnover In Multiple Myeloma: Impact Of Bortezomib-Based Induction Therapy, High-Dose Melphalan, and Lenalidomide Consolidation On Osteoblast and Osteoclast Function Within The GMMG-MM5 Trial

Role Of RECQ1 Helicase In Multiple Myeloma Biology and Drug Resistance

Expression Quantitative Trait Loci Reveal Regulatory Regions Important In The Pathogenesis of Multiple Myeloma

Malignant Plasma Cells Responsible for Multiple Myeloma Relapse Are Detectable and Survive Nine Days After High Dose Melphalan: Highlight of An Optimal Therapeutic Window ?

Umbilical Cord Blood Transplantion In Relapsed Multiple Myeloma

Immunophenotypic Analysis of Myeloma Precursors: Antigens for Therapeutic Targeting

Myeloma Cell Self-Renewal Depends on JAG2 Expression and Is Mediated by IGF1 or SCF Loop

Comparison of Immune Reconstitution after Umbilical Cord Blood (UCB) and Allogenic Peripheral Blood Stem Cell (APBSC) Transplantation in Patients with Advanced Multiple Myeloma (MM) and Acute Myeloid Leukemia (AML).

Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma.

Interest of FDG-PET Scanning for the Monitoring of Immunotherapies for Follicular Lymphoma.

Biological and Clinical Responses after Intradermal and Intravenous Administrations of Mature Dendritic Cells Loaded with Tumor Lysate in Follicular Lymphoma Patients.

Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Vaccination Strategies Determined by Microarray Analysis.

Characterization of Mesenchymal Stem Cells Abnormalities in Multiple Myeloma.

A Phase I/II Study of TACI-Ig To Neutralize APRIL and BLyS in Patients with Refractory or Relapsed Multiple Myeloma or Active Previously-Treated Waldenström’s Macroglobulinemia.

Efficient Vaccination of Follicular Lymphoma (FL) Patients with Multiple Intradermal (ID) and Intravenous (IV) Administrations of Mature Dendritic Cells (DC) Loaded with Tumor Cell Lysate Ex Vivo.

The Human Plasma Cell Gene Expression Program.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only